Global-Myasthenia-Gravis-Drugs-Market-Research-Report-2017
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
7.9 Catalyst Pharmaceuticals<br />
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors<br />
7.9.2 <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> Product Type, Application and Specification<br />
7.9.2.1 Product A<br />
7.9.2.2 Product B<br />
7.9.3 Catalyst Pharmaceuticals <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> Production, Revenue, Price and Gross<br />
Margin (2015 and 2016)<br />
7.9.4 Main Business/Business Overview<br />
7.10 CSL<br />
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors<br />
7.10.2 <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> Product Type, Application and Specification<br />
7.10.2.1 Product A<br />
7.10.2.2 Product B<br />
7.10.3 CSL <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> Production, Revenue, Price and Gross Margin (2015 and 2016)<br />
7.10.4 Main Business/Business Overview<br />
7.11 Curavac<br />
7.12 Cytokinetics<br />
7.13 Galencia<br />
7.14 GlaxoSmithKline<br />
7.15 Lupin Pharmaceuticals<br />
7.16 Mitsubishi Tanabe Pharma<br />
8 <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> Manufacturing Cost Analysis<br />
8.1 <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> Key Raw Materials Analysis<br />
8.1.1 Key Raw Materials<br />
8.1.2 Price Trend of Key Raw Materials
Change language